FDA Approves Companion Diagnostic for Triple-Negative Breast Cancer
The assay is the first companion diagnostic approved for identifying triple-negative breast cancer patients who are eligible for PD-L1 immunotherapy.
Read More
Search Results for: lung cancer
University of Manchester and Owlstone Medical Awarded £250,000 to Advance Asthma Diagnostics
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read More
Lymph Node Analysis Could Improve Melanoma Treatment Options
Studies are demonstrating the potential of the Parsortix system to enhance laboratory efficiency, reduce costs, support medical decisionmaking, and improve patient care.
Read MoreMRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostic
The companies’ collaboration underscores the need for proteomic data to enable precision medicine strategies for lung cancer patients.
Read MoreFDA Grants Breakthrough Device Designation for Companion Diagnostic by ArcherDx
If approved, the test could be the first FDA-approved multigene sequencing-based in vitro diagnostic to accept both plasma and FFPE-based inputs.
Read More